{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:56:35Z","timestamp":1768884995154,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,27]]},"DOI":"10.7759\/cureus.17484","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T12:18:55Z","timestamp":1630066735000},"source":"Crossref","is-referenced-by-count":2,"title":["Correlation Between Serum Ferritin and Hepcidin Levels in Chronic Hepatitis C Patients"],"prefix":"10.7759","author":[{"given":"Maria","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javaria","family":"Sharafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiza","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misbah","family":"Ul Qamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irum","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mannal","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Noreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Khadim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arusa","family":"Horii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakhtawar","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2020.100067","article-title":"Key milestones in HCV discovery and therapeutics","volume":"1","author":"Cheng X","year":"2020","unstructured":"Cheng X, Ghany MG. Key milestones in HCV discovery and therapeutics. Innovation. 2020, 1:100067. 10.1016\/j.xinn.2020.100067","journal-title":"Innovation"},{"key":"ref2","unstructured":"Global hepatitis report 2017. (2017). Accessed. 26th July, 2021: https:\/\/apps.who.int\/iris\/handle\/10665\/255016."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults - United States, 2020","volume":"69","author":"Schillie S","year":"2020","unstructured":"Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis C screening among adults - United States, 2020. MMWR Recomm Rep. 2020, 69:1-17. 10.15585\/mmwr.rr6902a1","journal-title":"MMWR Recomm Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1756284818759483","article-title":"Host-targeting therapies for hepatitis C virus infection: current developments and future applications","volume":"11","author":"Crouchet E","year":"2018","unstructured":"Crouchet E, Wrensch F, Schuster C, Zeisel MB, Baumert TF. Host-targeting therapies for hepatitis C virus infection: current developments and future applications. Therap Adv Gastroenterol. 2018, 11:1756284818759483. 10.1177\/1756284818759483","journal-title":"Therap Adv Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri A","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018, 155:629-47. 10.1053\/j.gastro.2018.06.083","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2019-0004","article-title":"Importance of studying the levels of hepcidin and vitamin D in Egyptian children with chronic hepatitis C","volume":"7","author":"Mohamed AA","year":"2019","unstructured":"Mohamed AA, Abd Almonaem ER, Mansour AI, Algebaly HF, Khattab RA, El Abd YS. Importance of studying the levels of hepcidin and vitamin D in Egyptian children with chronic hepatitis C. J Transl Int Med. 2019, 7:15-21. 10.2478\/jtim-2019-0004","journal-title":"J Transl Int Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2018.09.044","article-title":"Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection","volume":"133","author":"Hino K","year":"2019","unstructured":"Hino K, Nishina S, Sasaki K, Hara Y. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection. Free Radic Biol Med. 2019, 133:193-9. 10.1016\/j.freeradbiomed.2018.09.044","journal-title":"Free Radic Biol Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.232124","article-title":"Iron metabolism and iron disorders revisited in the hepcidin era","volume":"105","author":"Camaschella C","year":"2020","unstructured":"Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica. 2020, 105:260-72. 10.3324\/haematol.2019.232124","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(96)90337-8","article-title":"Iron overload in patients with chronic hepatitis C: a clinicopathologic study","volume":"27","author":"Haque S","year":"1996","unstructured":"Haque S, Chandra B, Gerber MA, Lok AS. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol. 1996, 27:1277-81. 10.1016\/s0046-8177(96)90337-8","journal-title":"Hum Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.202737","article-title":"Relationship between hepatitis C virus infection and iron overload","volume":"130","author":"Zou DM","year":"2017","unstructured":"Zou DM, Sun WL. Relationship between hepatitis C virus infection and iron overload. Chin Med J (Engl). 2017, 130:866-71. 10.4103\/0366-6999.202737","journal-title":"Chin Med J (Engl)"},{"key":"ref11","article-title":"Study of serum hepcidin in patients with chronic hepatitis C","volume":"30","author":"El Lehleh AM","year":"2017","unstructured":"El Lehleh AM, El Shazly RA, Hamza RR. Study of serum hepcidin in patients with chronic hepatitis C. Menoufia Med J. 2017, 30:721-6.","journal-title":"Menoufia Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01244.x","article-title":"Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C","volume":"17","author":"Tsochatzis E","year":"2010","unstructured":"Tsochatzis E, Papatheodoridis GV, Koliaraki V, et al.. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat. 2010, 17:800-6. 10.1111\/j.1365-2893.2009.01244.x","journal-title":"J Viral Hepat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000480743","article-title":"Clinical implications of new insights into hepcidin-mediated regulation of iron absorption and metabolism","volume":"71 Suppl 3","author":"Prentice AM","year":"2017","unstructured":"Prentice AM. Clinical implications of new insights into hepcidin-mediated regulation of iron absorption and metabolism. Ann Nutr Metab. 2017, 71 Suppl 3:40-8. 10.1159\/000480743","journal-title":"Ann Nutr Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.06.027","article-title":"Reduced serum hepcidin levels in patients with chronic hepatitis C","volume":"51","author":"Girelli D","year":"2009","unstructured":"Girelli D, Pasino M, Goodnough JB, et al.. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol. 2009, 51:845-52. 10.1016\/j.jhep.2009.06.027","journal-title":"J Hepatol"},{"key":"ref15","article-title":"Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C","volume":"39","author":"Aoki CA","year":"2005","unstructured":"Aoki CA, Rossaro L, Ramsamooj R, Brandhagen D, Burritt MF, Bowlus CL. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. J Clin Gastroenterol. 2005, 39:71-4.","journal-title":"J Clin Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20203352","article-title":"Correlation of hepcidin and serum ferritin levels in thalassemia patients at Chiang Mai University Hospital","volume":"41","author":"Tantiworawit A","year":"2021","unstructured":"Tantiworawit A, Khemakapasiddhi S, Rattanathammethee T, et al.. Correlation of hepcidin and serum ferritin levels in thalassemia patients at Chiang Mai University Hospital. Biosci Rep. 2021, 41:BSR20203352. 10.1042\/BSR20203352","journal-title":"Biosci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67526-correlation-between-serum-ferritin-and-hepcidin-levels-in-chronic-hepatitis-c-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:38Z","timestamp":1707507278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67526-correlation-between-serum-ferritin-and-hepcidin-levels-in-chronic-hepatitis-c-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.17484","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,27]]}}}